6-K - Genmab A/S | StockGist

AI Analysis

AI-generated analysis. Always verify with the original filing.

Following its Annual General Meeting on March 19, 2026, Genmab A/S constituted its Board of Directors, appointing Ms. Deirdre P. Connelly as Chair and Ms. Pernille Erenbjerg as Deputy Chair. The Board granted 5,213 restricted stock units (fair value DKK 1,645 each) and 4,485 warrants (exercise price DKK 1,645, fair value DKK 530.62 each) to employees of the Company and subsidiaries.

Key Takeaways

1Ms. Deirdre P. Connelly appointed Chair of the Board of Directors on March 19, 2026

2Ms. Pernille Erenbjerg appointed Deputy Chair of the Board of Directors on March 19, 2026

35,213 restricted stock units granted to employees, each with fair value DKK 1,645

44,485 warrants granted to employees, each with exercise price DKK 1,645 and fair value DKK 530.62

5Restricted stock units vest on first banking day after three years from grant date

6Warrants vest three years after grant date and expire at seventh anniversary

Current Report Details

Event Type

Securities Issuance

Disclosure

Voluntary

Variant

6-K

Items Reported

6-K

Current Report on Form 6-K

Securities Issuance

Executive & Director Changes

Deirdre P. Connelly

Chair of the Board of Directors

appointed

Effective: 2026-03-19

Pernille Erenbjerg

Deputy Chair of the Board of Directors

appointed

Effective: 2026-03-19

Exhibits (2)

6-K

99.1

EX-99.1